First published 9/28/2026, 6:08:15 AM · Last updated 9/28/2026, 6:08:30 AM

Shenqi Yanshen Decoction protects against renal and bone injury in chronic kidney disease–mineral and bone disorder with potential involvement of Wnt5a/RhoA/Pkn3 signaling

A peer-reviewed article reports that the traditional formulation Shenqi Yanshen Decoction reduced renal and bone injury in chronic kidney disease–mineral and bone disorder and suggests involvement of Wnt5a/RhoA/Pkn3 signaling. Publication metadata lists Elsevier BV and a publication date of 2027-02-01.

Categories: science-and-space, public-health, positive-progress

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The finding presents a potential therapeutic and mechanistic insight relevant to CKD–MBD research.

Sources

Shenqi Yanshen Decoction protects against renal and bone injury in chronic kidney disease–mineral and bone disorder with potential involvement of Wnt5a/RhoA/Pkn3 signaling

Report an issue